http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9101613-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bb9720517997b2ead951733c2695d8a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 |
| filingDate | 2013-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ab27425d8f0584bcfefbc5d6e4357f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca50092a70501d300c05e454c846e703 |
| publicationDate | 2015-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-9101613-B2 |
| titleOfInvention | Methods for treating neurological disease |
| abstract | Neurological disorders and diseases, such as Alzheimer's disease, Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS) and Down's syndrome, can be ameliorated or beneficially treated by administration of a formulation comprising an effective amount of a pyrone-indole derivative of formula (I)n nAr—B—Ar′ (I)n nwherein AR represents an indole nucleus ring system:n n nAr′ represents an alpha-, beta- or gamma-pyrone nucleus ring system:n n nand each of B, R 1 , R 2 , R 3 , R 4 , R 1 ′ and R 2 ′ are as defined herein. |
| priorityDate | 2006-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1320.